Childhood craniopharyngioma—current concepts in diagnosis, therapy and follow-up
- 28 September 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Endocrinology
- Vol. 6 (11), 609-618
- https://doi.org/10.1038/nrendo.2010.168
Abstract
Craniopharyngiomas have an overall incidence of 0.5-2.0 new cases per million of the population per year, and ∼30-50% of all cases represent childhood craniopharyngioma. These partly cystic embryogenic malformations of the sellar region are presumably derived from Rathke cleft epithelium. Many of the typical manifestations at primary diagnosis are nonspecific and include headache, visual impairment, polyuria and/or polydypsia, growth retardation and weight gain. Total resection is the treatment of choice in patients with favorable tumor localization, with the intention to maintain hypothalamic-pituitary and optical nerve functions. When the tumor localization is unfavorable, a limited resection followed by local irradiation is recommended. The overall survival rates are high (91-98%). High recurrence rates after complete resection and high progression rates after incomplete resection have been observed, although the risk of recurrence or progression is less after complete resection than partial resection. Irradiation of the tumor is protective and the appropriate time point of irradiation after incomplete resection is currently under investigation in a randomized trial. Long-term sequelae substantially reduce the quality of life of ∼50% of long-term survivors, notably extreme obesity owing to hypothalamic involvement.Keywords
This publication has 96 references indexed in Scilit:
- Childhood CraniopharyngiomaHormone Research in Paediatrics, 2008
- Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapyNature Clinical Practice Endocrinology & Metabolism, 2007
- Melatonin Treatment in Obese Patients with Childhood Craniopharyngioma and Increased Daytime SleepinessCancer Causes & Control, 2006
- GH replacement does not increase the risk of recurrence in patients with craniopharyngiomaClinical Endocrinology, 2006
- Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive functionJournal of Neurosurgery: Pediatrics, 2006
- Quality of life and behavioral follow-up study of pediatric survivors of craniopharyngiomaJournal of Neurosurgery: Pediatrics, 2005
- Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngiomaThe Journal of Pathology, 2004
- β-Catenin Is Expressed Aberrantly in Tumors Expressing Shadow CellsAmerican Journal of Clinical Pathology, 2003
- Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001International Journal of Radiation Oncology*Biology*Physics, 2002
- Obesity after childhood craniopharyngioma - German multicenter study on pre-operative risk factors and quality of lifeKlinische Padiatrie, 2001